# Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery

> **NCT00723216** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 151 (actual)

## Conditions studied

- Abdominal Neoplasms

## Interventions

- **DRUG:** enoxaparin
- **OTHER:** Physical prophylaxis

## Key facts

- **NCT ID:** NCT00723216
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2010-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00723216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00723216, "Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00723216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*